NYSE: CBChubb Ltd Stock
$266.70+0.20 (+0.08%)
Updated Jan 24, 2025
CB Price
$266.70
Fair Value Price
N/A
Market Cap
$107.51B
52 Week Low
$238.85
52 Week High
$302.05
P/E
10.84x
P/B
1.63x
P/S
2.14x
PEG
20.84x
Dividend Yield
1.35%
Revenue
$54.57B
Earnings
$10.00B
Gross Margin
44.5%
Operating Margin
20.85%
Profit Margin
18.3%
Debt to Equity
2.74
Operating Cash Flow
$15B
Beta
0.81
Next Earnings
Jan 28, 2025
Ex-Dividend
N/A
Next Dividend
N/A
CB Overview
Chubb Limited offers commercial and personal property and casualty insurance, personal accident and supplemental health insurance, life insurance, and reinsurance. Chubb operates in 55 countries and territories and the Lloyd's insurance market in London. The company was founded in 1985 and is headquartered in Zürich, Switzerland.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CB's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Value
D
Growth
C
Momentum
B
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Property & Casualty Insurance
Industry Rating
A
CB
Ranked#29 of 37
Ranked#29 of 37
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $15.23 | A | |
| $25.27 | A | |
| $186.07 | A |
Be the first to know about important CB news, forecast changes, insider trades & much more!
CB News
Overview
Due Diligence Score
–
Industry Average (38)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CB scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CB ($266.70) is trading above its intrinsic value of $133.45, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CB is good value based on its earnings relative to its share price (10.84x), compared to the US market average (30.33x)
P/E vs Market Valuation
CB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CB due diligence checks available for Premium users.
Valuation
CB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
10.84x
Industry
13.28x
Market
30.33x
CB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CB is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.63x
Industry
2.15x
CB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CB price to earnings growth (PEG)
For valuing profitable companies with growth potential
CB is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CB's financial health
Profit margin
Revenue
$14.8B
Net Income
$2.3B
Profit Margin
15.7%
CB's Earnings (EBIT) of $11.38B... subscribe to Premium to read more.
Interest Coverage Financials
CB's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$250.6B
Liabilities
$180.4B
Debt to equity
2.74
CB's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$4.3B
Investing
-$5.4B
Financing
$1.1B
CB's operating cash flow ($14.80B)... subscribe to Premium to read more.
Debt Coverage Financials
CB vs Property & Casualty Insurance Stocks
Chubb Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.